Improving Outcomes for Infants After Cardiopulmonary Bypass Surgery for Congenital Heart Disease: A Commentary on Recent Randomized Controlled Trials.
Publication
, Journal Article
Schlapbach, LJ; Gibbons, KS; Butt, W; Kannankeril, PJ; Li, JS; Hill, KD ...
Published in: Pediatr Crit Care Med
November 1, 2023
The recent NITRIC and STRESS trials demonstrate opportunities to perform pragmatic large randomized trials in congenital heart disease. We discuss lessons learnt from these trials which can inform future trial design and conduct in the field of pediatric heart surgery.
Duke Scholars
Altmetric Attention Stats
Dimensions Citation Stats
Published In
Pediatr Crit Care Med
DOI
ISSN
1529-7535
Publication Date
November 1, 2023
Volume
24
Issue
11
Start / End Page
961 / 965
Location
United States
Related Subject Headings
- Randomized Controlled Trials as Topic
- Pediatrics
- Infant
- Humans
- Heart Defects, Congenital
- Cardiopulmonary Bypass
- Cardiac Surgical Procedures
- 4205 Nursing
- 3213 Paediatrics
- 3202 Clinical sciences
Citation
APA
Chicago
ICMJE
MLA
NLM
Schlapbach, L. J., Gibbons, K. S., Butt, W., Kannankeril, P. J., Li, J. S., Hill, K. D., & Nitric Oxide During Cardiopulmonary Bypass to Improve Recovery in Infants With Congenital Heart Defects Follow-Up (NITRIC) Study Group and the Steroids to Reduce Systemic Inflammation after Infant Heart Surgery (STRESS) Network Investigators. (2023). Improving Outcomes for Infants After Cardiopulmonary Bypass Surgery for Congenital Heart Disease: A Commentary on Recent Randomized Controlled Trials. Pediatr Crit Care Med, 24(11), 961–965. https://doi.org/10.1097/PCC.0000000000003344
Schlapbach, Luregn J., Kristen S. Gibbons, Warwick Butt, Prince J. Kannankeril, Jennifer S. Li, Kevin D. Hill, and Nitric Oxide During Cardiopulmonary Bypass to Improve Recovery in Infants With Congenital Heart Defects Follow-Up (NITRIC) Study Group and the Steroids to Reduce Systemic Inflammation after Infant Heart Surgery (STRESS) Network Investigators. “Improving Outcomes for Infants After Cardiopulmonary Bypass Surgery for Congenital Heart Disease: A Commentary on Recent Randomized Controlled Trials.” Pediatr Crit Care Med 24, no. 11 (November 1, 2023): 961–65. https://doi.org/10.1097/PCC.0000000000003344.
Schlapbach LJ, Gibbons KS, Butt W, Kannankeril PJ, Li JS, Hill KD, et al. Improving Outcomes for Infants After Cardiopulmonary Bypass Surgery for Congenital Heart Disease: A Commentary on Recent Randomized Controlled Trials. Pediatr Crit Care Med. 2023 Nov 1;24(11):961–5.
Schlapbach, Luregn J., et al. “Improving Outcomes for Infants After Cardiopulmonary Bypass Surgery for Congenital Heart Disease: A Commentary on Recent Randomized Controlled Trials.” Pediatr Crit Care Med, vol. 24, no. 11, Nov. 2023, pp. 961–65. Pubmed, doi:10.1097/PCC.0000000000003344.
Schlapbach LJ, Gibbons KS, Butt W, Kannankeril PJ, Li JS, Hill KD, Nitric Oxide During Cardiopulmonary Bypass to Improve Recovery in Infants With Congenital Heart Defects Follow-Up (NITRIC) Study Group and the Steroids to Reduce Systemic Inflammation after Infant Heart Surgery (STRESS) Network Investigators. Improving Outcomes for Infants After Cardiopulmonary Bypass Surgery for Congenital Heart Disease: A Commentary on Recent Randomized Controlled Trials. Pediatr Crit Care Med. 2023 Nov 1;24(11):961–965.
Published In
Pediatr Crit Care Med
DOI
ISSN
1529-7535
Publication Date
November 1, 2023
Volume
24
Issue
11
Start / End Page
961 / 965
Location
United States
Related Subject Headings
- Randomized Controlled Trials as Topic
- Pediatrics
- Infant
- Humans
- Heart Defects, Congenital
- Cardiopulmonary Bypass
- Cardiac Surgical Procedures
- 4205 Nursing
- 3213 Paediatrics
- 3202 Clinical sciences